7 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
between SGLT-2 inhibitors ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes ... renal #SGLT2i #Inhibitors
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Synjardy (metformin + empagliflozin ... Xigduo (metformin + dapagliflozin ... (linagliptin + empagliflozin ... ) • Qtern (dapagliflozin ... Pharmacology #Pills #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... the three • Dapagliflozin ... loss (~2-3kg) • Empagliflozin ... • Euglycemic diabetic ... #endocrinology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
treatment of type II diabetes ... (Invokana®), dapagliflozin ... (Farxiga®) and empagliflozin ... , #dapagliflozin ... , #empagliflozin
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... • SGLT2i (Dapagliflozin ... sarahthelyon #Diabetes ... pathophysiology #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... class of anti-diabetic ... the first one (Canagliflozin ... Medications #DM2 #Diabetes ... #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
compared to SGLT2 empagliflozin ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology